Related Experiment Videos
[Acebutolol in the treatment of arterial hypertension. Clinical study]
Insights
This study found that acebutolol, a beta-blocker, effectively treated hypertension in 74% of patients. Acebutolol was well-tolerated, making it a good option for specific hypertension types.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Hypertension remains a significant global health challenge.
- Identifying effective and well-tolerated antihypertensive medications is crucial.
- Specific patient profiles may benefit from targeted therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy and tolerability of acebutolol in hypertensive patients.
- To determine the effectiveness of acebutolol as monotherapy or in combination with other antihypertensives.
- To identify patient subgroups who are good candidates for acebutolol treatment.
Main Methods:
- An open-label therapeutic trial was conducted over one year.
- Fifty patients diagnosed with hypertension participated in the study.
- Acebutolol was administered alone or in conjunction with other hypotensive agents.
Main Results:
- Good or moderate treatment outcomes were observed in 74% of patients.
- Treatment failure occurred in 26% of the study participants.
- Acebutolol demonstrated good tolerability with a mean dosage of 10 mg/kg (max 22 mg/kg).
Conclusions:
- Acebutolol is an effective antihypertensive medication, achieving good or moderate results in a majority of patients.
- The drug is well-tolerated, suggesting a favorable safety profile.
- Hypertension with increased cardiac index and renovascular hypertension with elevated plasma renin activity are identified as suitable indications for acebutolol therapy.
Abstract:
Fifty hypertensive patients were given a beta-blocker, acebutolol, alone or in association with other hypotensive drugs, in an open therapeutic trial lasting for a year. The results of treatment were considered to be good or moderate in 74 p.cent of the patients. Treatment failures were recorded in 26 p.cent. The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated. Hypertension with an increased cardiac index and reno-vascular hypertension with increased plasma renin activity are good indications for acebutolol.